Glenmark makes leadership changes
Glenmark has named Anurag Mantri as president, effective April 7.
V.S. Mani, executive director and global chief financial officer of the company is opting for early retirement and has decided to step down from the position May 26.
Mantri served as executive director and group chief finance officer of Jindal Stainless since 2016. In a regulatory filing on March 21, Jindal Stainless Limited said Mantri had resigned for other opportunities and he would cease to be the executive director and group CFO from the close of business hours of April 4, 2025, per a CNBC18 report. The report also noted that Mantri's expertise spans enterprise value creation, IPO management, global compliance, mergers and acquisitions and corporate finance. He has previously held significant roles at Larsen & Toubro, HCL Technologies, SRF Limited, Cairn Energy, ACME Group (Solar), and Schneider Electric Infrastructure Limited. He holds a Bachelor of Commerce degree from the University of Rajasthan.
[Read more: Glenmark releases generic Travatan Z]
Following approval by the Audit Committee, Nomination & Remuneration Committee and Glenmark board, Mantri will also become executive director and global chief financial officer.
To enable a smooth transition, Mani has agreed to continue with the company for some time.
In his resignation letter, Mani said, "After an enriching journey of about eight years with the Company, and considering that I have crossed 60 years of age and have decided to take early retirement. I have decided to step down from my position as Executive Director & Global Chief Financial Officer...I am deeply grateful for the unwavering support of Mr. Glenn Saldanha, the Chairman & Managing Director, fellow Board members, my peers, my team and all other colleagues in the organization whose dedication and vision have been instrumental in shaping the company's success... As I move forward, I extend my best wishes to Glenmark for its continued growth and prosperity."
[Read more: Glenmark debuts Olopatadine Hydrochloride Ophthalmic Solution OTC]